C4 Therapeutics
Roy Pollock is a Senior Vice President at C4 Therapeutics, Inc. Currently overseeing Biological Sciences, Pollock previously held roles as Vice President at Warp Drive Bio, LLC, Senior Director at Epizyme, Inc., and Research Fellow at Merck. Roy has a solid background in cancer epigenetics, target validation, and drug discovery for chromatin modifying enzymes. With a Ph.D. in Molecular Biology from Massachusetts Institute of Technology, Pollock has contributed significantly to the development of novel technologies for small molecule regulation of cell signaling and gene expression for use in gene and cell therapies.
This person is not in the org chart
C4 Therapeutics
6 followers
C4 Therapeutics (C4T) is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.